Moreover, RIG-1 loss of expression was correlated with poor clinicopathological features, due to its capacity in inhibiting the proliferation, migration, and invasion of HCC through the down-regulation of the matrix metallo-proteinases-9 (MMP9), involved in the proteolytic degradation of the extracellular matrix [231]. This evidence concerns the gene PLAAT4 and hepatocellular carcinoma.